Biomarkers & Assays: A Landscape Review in Lung Cancer
Time: 4:50 pm
day: Day 2 PM
Details:
- An overview of the preclinical and clinical lung cancer biomarker landscape
- A breakdown and analysis of the current lung cancer assay landscape
- A review of the current regulatory landscape for lung cancer biomarkers and assays
